Search

everythinglearnresearchcommunity

for

Search:↓

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Trichoscopy helps diagnose hair and scalp problems but isn't always definitive and should be used with other methods.

The comment questions the study's methods for diagnosing hair loss, the type of injections used, the reliability of hair count as a measure, the lack of detail about the procedure, and disagrees with the conclusion about the effect of needling.

Different types of PCOS need specific diagnosis methods and treatments.

A scalp biopsy can help confirm hair loss types when other methods don't provide a clear diagnosis.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Trichoscopy is a useful tool for diagnosing and managing hair and scalp conditions, often better than traditional methods.

The conclusion is that treating scalp AVF caused by hair transplantation with endovascular methods like coiling is safe and effective.

Both vertical and transverse sections are useful for diagnosing alopecia, but using both methods together is best.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

The document discusses male and female pattern hair loss, its diagnosis methods, FDA-approved treatments like finasteride and minoxidil, their side effects, and the role of lifestyle changes.

The document concludes that breast pain should be managed with personalized treatment, starting with non-drug methods and progressing to medication if necessary, while considering side effects and patient needs.

The document explains hair growth and shedding, factors affecting it, and methods to evaluate hair loss, emphasizing the importance of skin biopsy for diagnosis.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

Accurate clinical, histological, and genetic methods are key for understanding and treating hair disorders.

The document concludes that choosing the right biopsy site is crucial for accurate alopecia diagnosis, and combining methods can improve results.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Children's hair loss can be caused by various factors and should be treated with appropriate, age-specific methods and psychological support.

The document concludes that patient outcomes for Congenital Adrenal Hyperplasia are often not ideal because of poor management and a need for better diagnosis and treatment methods.

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

Certain black hairstyling practices increase the risk of traction alopecia, requiring better management and education.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Transverse sections are better for non-scarring hair loss, vertical sections are better for lichen planopilaris, and either method works for other scarring hair loss types.

The article discusses various treatments for different types of non-scarring hair loss.

Hair and nails can help diagnose diseases, with nail issues often linked to skin conditions and hair loss having various causes and treatments.

The document concludes that the trichogram is a useful tool for diagnosing hair loss and suggests semi-organ cultures for practical trichological research.

Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.

Follicle Stimulating Hormone is important for fertility.